Jrsis Health Care Corporation JRSS

FY2023 · ended Dec 31, 2023 · Revenue $3.46M, +101.4% YoY · Filed Apr 26, 2024

Jrsis Health Care Corporation (JRSS) files with the SEC under industry code 8060, Services-Hospitals. In fiscal 2023, which ended Dec 31, 2023, it reported revenue of $3.5 million and a net loss of $80,912. Free cash flow was $515,240. As of Sep 30, 2024 it held $1,372 in cash and investments and $1.3 million in total debt.

Revenue (TTM)
$3.47M
Net income (TTM)
$-489,980
Operating cash flow (TTM)
$-730,303
+83.2% vs year-ago TTM
Free cash flow (TTM)
$-917,886
EPS (TTM)
$-0.01
Dividend per share
None
Shares outstanding
82.59M
+41.5% vs prior year
Net cash
$-1.34M
as of Sep 30, 2024
Operating margin
-19.5%
FY 2024

Company profile

Industry
Services-Hospitals (SIC 8060)
Listed as
JRSS (OTC)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Wuguishan, Zhongshan City, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1597892

Other Services-Hospitals companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
Revenue
$3.5M
$1.7M
$44.4M
$35.7M
$31.5M
Operating income
-$188,598
-$684,776
-$103,801
$5.6M
$4.7M
Net income
-$80,912
-$575,839
$3.2M
$3.8M
$888,061
Diluted EPS
-$0.00
-$0.01
$0.17
$0.15
$0.05
Operating cash flow
$516,724
-$1.8M
$8.2M
$10.6M
$11.8M
Free cash flow
$515,240
-$1.8M
$5.9M
$2.4M
$7.1M
Total assets
$2.1M
$2.0M
$75.7M
$58.8M
$51.6M
Total liabilities
$2.3M
$2.1M
$42.6M
$30.0M
$28.6M
Stockholders' equity
-$137,406
-$58,453
$22.1M
$19.0M
$14.8M
Cash and investments
$118,114
$158,813
$73,253
$844,827
$2.0M
Total debt
$46,940
$9,595
$20.4M
$16.7M
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Dec 20, 2024 Sep 30, 2024
10-Q Quarterly report Sep 5, 2024 Jun 30, 2024
10-Q Quarterly report May 29, 2024 Mar 31, 2024
10-K Annual report Apr 26, 2024 Dec 31, 2023
8-K Current report
Auditor change
Apr 11, 2024 Dec 13, 2023
8-K Current report
Officer or director change
Dec 11, 2023 Dec 11, 2023

Source: SEC EDGAR filings. This is company-reported data, not investment advice.